Stonebridge’s first fund invests more than half of committed capital Fund deploys capital across sectors including biotech, technology, logistics and food
Translated by Ryu Ho-joung 공개 2021-09-23 07:37:42
이 기사는 2021년 09월 23일 07시31분 thebell에 표출된 기사입니다
Seoul-based private equity firm Stonebridge Capital’s first bind-pool fund has deployed more than half of its committed capital, only about a year after the fund began investing.Stonebridge Mid Cap I, which closed in July 2020 with 306 billion won ($260 million) in commitments, has invested roughly 187 billion won to date, which represents about 60% of its committed capital.
The ratio of invested capital to committed capital is likely to increase to 75% before the end of the year when considering two more deals in the pipeline.
Most recently the private equity firm signed a deal to acquire nutritional supplement company Health balance for 80 billion won in partnership with Daehan Flour Mill, with about 50 billion won of the acquisition cost set to be financed through the fund. The deal is expected to close next month.
The fund’s other portfolio companies include Texas-based Caris Life Sciences and Cloocus, a cloud managed service provider and cloud partner of Microsoft Azure. The fund also invested in AJ Total’s chilled and frozen warehouse business, content production studio Realies Pictures and golf service platform company Kakao VX earlier this year.
The fund focuses on middle-market high growth companies. Its limited partners include domestic institutional investors such as Korea Development Bank, Teachers’ Pension and the Pension Foundation of the General Assembly of the Presbyterian Church of Korea. (Reporting by Ha-na Suh)
< 저작권자 ⓒ 자본시장 미디어 'thebell', 무단 전재, 재배포 및 AI학습 이용 금지 >
best clicks
최신뉴스 in 전체기사
-
- '비상경영체 돌입' SKT, 유심 사태 수습 '총력전'
- 위메이드 "위믹스 해킹 늑장공시 아니야…DAXA 기준 불분명"
- [Market Watch]DN솔루션즈 이어 롯데글로벌까지, 대형 IPO '휘청'
- [롯데글로벌로지스 IPO]흥행 실패 우려, 결국 상장 철회로 귀결
- [AACR 2025]제이인츠 'JIN-001', 독성 최소화한 '저농도' 효능 입증
- [Financial Index/SK그룹]주가상승률 50% 상회, SK스퀘어 'TSR' 그룹내 최고
- 금호타이어, 분기 '최대 매출'…영업이익은 '주춤'
- 유지한 SKC CFO "트럼프 관세, 위기보다 기회"
- [i-point]신테카바이오, 'K-BioX 글로벌 SUMMIT 6' 참여
- 간추려진 대명소노그룹 선택지, '티웨이'에 집중